{
    "organizations": [],
    "uuid": "95eb7d897169e1176a55596344546292bc3a1b06",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-egalet-says-filed-patent-infringem/brief-egalet-says-filed-patent-infringement-lawsuit-against-teva-pharmaceuticals-usa-idUSFWN1RI056",
    "ord_in_thread": 0,
    "title": "BRIEF-Egalet Says Filed Patent Infringement Lawsuit Against Teva Pharmaceuticals USA",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 5 (Reuters) - Egalet Corp:\n* EGALET SAYS ON APRIL 4 UNITS OF CO FILED A PATENT INFRINGEMENT LAWSUIT IN U.S. DISTRICT COURT AGAINST TEVA PHARMACEUTICALS USA, INC - SEC FILING\n* EGALET - LAWSUIT FILED FOR TEVA'S INFRINGEMENT OF A PATENT FOR ARYMO ER LISTED IN APPROVED DRUG PRODUCTS WITH THERAPEUTIC EQUIVALENCE EVALUATIONS Source: ( bit.ly/2uMR3CW ) Further company coverage:\n ",
    "published": "2018-04-05T18:37:00.000+03:00",
    "crawled": "2018-04-06T21:42:37.108+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "egalet",
        "corp",
        "egalet",
        "say",
        "april",
        "unit",
        "co",
        "filed",
        "patent",
        "infringement",
        "lawsuit",
        "district",
        "court",
        "teva",
        "pharmaceutical",
        "usa",
        "inc",
        "sec",
        "filing",
        "egalet",
        "lawsuit",
        "filed",
        "teva",
        "infringement",
        "patent",
        "arymo",
        "er",
        "listed",
        "approved",
        "drug",
        "product",
        "therapeutic",
        "equivalence",
        "evaluation",
        "source",
        "company",
        "coverage"
    ]
}